This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Acceptance-Based Treatment for Generalized Anxiety Disorder

This study has been completed.
National Institute of Mental Health (NIMH)
Information provided by:
University of Massachusetts, Boston Identifier:
First received: December 2, 2003
Last updated: November 5, 2013
Last verified: September 2008
This study will develop and implement an awareness- and acceptance-based for treatment of individuals with generalized anxiety disorder.

Condition Intervention Phase
Anxiety Disorders Generalized Anxiety Disorder Behavioral: Acceptance Based Behavioral Therapy Phase 1

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Developing a New Therapy for GAD: Acceptance-Based CBT

Resource links provided by NLM:

Further study details as provided by University of Massachusetts, Boston:

Primary Outcome Measures:
  • Clinician Severity Rating from ADIS for GAD [ Time Frame: pre, post, 3 mo. f/u, 9 mo. f/u ]
  • Penn State Worry Questionnaire [ Time Frame: pre-, post-, 3 mo. f/u, 9 mo. f/u ]
  • Depression Anxiety and Stress Scales, anxiety and stress subscales [ Time Frame: pre-, post-, 3 mo. f/u, 9 mo. f/u ]

Enrollment: 50
Study Start Date: May 2002
Study Completion Date: August 2006
Primary Completion Date: July 2006 (Final data collection date for primary outcome measure)
Detailed Description:
Participants in this study are recruited from intakes at the Center for Anxiety and Related Disorders at Boston University. Participants will be randomly assigned to receive either acceptance and mindfulness-based strategies plus cognitive behavioral therapy or no treatment for 16 weeks. The treatment will involve daily practice of mindfulness techniques to help draw attention to and accept various emotional states. Interviews, questionnaires, and depression and anxiety scales will be used to assess participants. Assessments will be conducted post-treatment and at 3- and 9-month follow-up visits.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Generalized Anxiety Disorder (GAD)
  • Willing to maintain medication levels and refrain from any additional psychosocial treatment during the course of the study

Exclusion Criteria:

  • Bipolar disorder, psychotic disorder, or substance dependence
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00073632

United States, Massachusetts
Center for Anxiety and Related Disorders
Boston, Massachusetts, United States
Sponsors and Collaborators
University of Massachusetts, Boston
National Institute of Mental Health (NIMH)
Principal Investigator: Lizabeth Roemer, PhD University of Massachusetts, Boston
Principal Investigator: Susan M Orsillo, PhD Boston University
  More Information

Responsible Party: Lizabeth Roemer, Ph. D., University of Massachusetts Boston Identifier: NCT00073632     History of Changes
Other Study ID Numbers: R21MH063208 ( U.S. NIH Grant/Contract )
Study First Received: December 2, 2003
Last Updated: November 5, 2013

Additional relevant MeSH terms:
Anxiety Disorders
Pathologic Processes
Mental Disorders processed this record on September 21, 2017